Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)
Income Statement
Others
Ratios

Neogen (NEOG) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 -14.29%
Nov 30, 2025 -141.18%
Aug 31, 2025 106.03%
May 31, 2025 -5,540.00%
Feb 28, 2025 97.62%
Nov 30, 2024 -3,400.00%
Aug 31, 2024 -200.00%
May 31, 2024 -100.00%
Feb 29, 2024 50.00%
Nov 30, 2023 -300.00%
Aug 31, 2023 -75.00%
May 31, 2023 0.00%
Feb 28, 2023 121.05%
Nov 30, 2022 -480.00%
Aug 31, 2022 -64.29%
May 31, 2022 180.00%
Feb 28, 2022 -50.00%
Nov 30, 2021 -37.50%
Aug 31, 2021 6.67%
May 31, 2021 25.00%
Feb 28, 2021 -20.00%
Nov 30, 2020 0.00%
Aug 31, 2020 0.00%
May 31, 2020 36.36%
Feb 29, 2020 -26.67%
Nov 30, 2019 7.14%
Aug 31, 2019 -53.33%
May 31, 2019 20.00%
Feb 28, 2019 -19.35%
Nov 30, 2018 6.90%
Aug 31, 2018 -12.12%
May 31, 2018 3.13%
Feb 28, 2018 -3.03%
Nov 30, 2017 43.48%
Aug 31, 2017 -4.17%
May 31, 2017 20.00%
Feb 28, 2017 -9.09%
Nov 30, 2016 10.00%
Aug 31, 2016 -23.08%
May 31, 2016 18.18%
Feb 29, 2016 -8.33%
Nov 30, 2015 -4.00%
Aug 31, 2015 0.00%
May 31, 2015 25.00%
Feb 28, 2015 -4.76%
Nov 30, 2014 -12.50%
Aug 31, 2014 20.00%
May 31, 2014 11.11%
Feb 28, 2014 5.88%
Nov 30, 2013 -19.05%
Aug 31, 2013 10.53%
May 31, 2013 0.00%
Feb 28, 2013 5.56%
Nov 30, 2012 -5.26%
Aug 31, 2012 -24.00%
May 31, 2012 13.64%
Feb 29, 2012 0.00%
Nov 30, 2011 -12.00%
Aug 31, 2011 0.00%
May 31, 2011 19.05%
Feb 28, 2011 -19.23%
Nov 30, 2010 4.00%